ReWalk Robotics (NSDQ:RWLK) said today it won coverage and reimbursement for its ReWalk Personal exoskeleton systems from a commercial health plan in the Northwest region of the U.S. The approval was made following the ruling of an independent review organization that overturned an initial denial of coverage. The Israeli comapny said the beneficiary in the […]
ReWalk Robotics (NSDQ:RWLK) said today that the Department of Veterans Affairs released details of a planned 4-year, national, multi-center study of ReWalk’s Personal 6.0 exoskeleton systems. The aptly named Exoskeleton Assisted-Walking in Persons with SCI: Impact on Quality of Life study is slated to enroll 160 patients at 6 participating VA Medical Centers across California, Florida, Massachusetts, […]
ReWalk Robotics (NSDQ:RWLK) said yesterday that the U.S. Department of Veterans Affairs issued a policy to evaluate, train and procure its personal exoskeleton systems for all qualifying veterans in the U.S. ReWalk develops and produces exoskeletons designed to restore self-initiated walking for patients with spinal cord injuries. The personal system is battery-powered and features an […]
Stryker (NYSE:SYK) said yesterday that it’s eliminating the role of international president held by Ramesh Subrahmanian as it reorganizes its overseas business. After Subrahmanian’s departure, effective Dec. 31, he’s slated to stay on until March 31, 2016, as an advisor, Stryker said in a regulatory filing. International sales were down across the board during Stryker’s […]
Reva Medical (ASX:RVA) said last week it picked up ex-Medtronic (NYSE:MDT) divisional veep Regina Groves as its new CEO. Groves was vice president and GM of the atrial fibrillation solutions, cardiac rhythm and heart failure division at Medtronic. During her time there, she helped the company strategize a re-entry into the catheter-based atrial fibrillation ablation market, the […]
ReWalk Robotics (NSDQ:RWLK) saw shares plummet as it reported 2nd quarter earnings that widely missed analysts marks and larger losses compared to the same quarter last year. ReWalk reported losses of $5.8 million, or 48¢ per share, on sales of $610,000 for the 3 months ended June 30. That amounts to a 23.8% bottom-line loss on […]
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.